Patent · US Active

Methods of treatment of malignancies

US10137130B2 · kind B2 · utility

7Cited by

1References

16Claims

0Family size

Assignees

CELGENE CORPORATION · US
Agios Pharmaceuticals, Inc. · US

Inventors

Michael Amatangelo · Newtown, US
Xiaolan Hu · Skillman, US
Anjan Thakurta · Jalan Pedongkelan, US
Sung Eun Choe · Lexington, US
Bin Wu · Thousand Oaks, US

Key dates

Filing date	Dec 2, 2016
Grant date	Nov 27, 2018
Priority date	—
Expiry date	Dec 2, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.